Tanaka et al. investigated HCC development in 1,927 HCV antibody-positive blood donors and found that the incidence of HCC was lower in subjects with a low ALT level compared to those with a high ALT level [58]. The gene discussed is GPT; the disease is hepatocellular carcinoma.